IL1A and Alzheimer disease: To test whether these changes mediate excessive dermal γδT cell accumulation in AD-like skin, we i.p. administered an IL-1R antibody to HDM/SEB-treated SSKO and WT mice to block IL-1 signaling (Fig. 6L).